New Insights into COPD Treatment: Potential of Cancer Drugs

Understanding Chronic Obstructive Pulmonary Disease (COPD)

Chronic obstructive pulmonary disease (COPD) encompasses a range of progressive inflammatory lung conditions, including chronic bronchitis, emphysema, and refractory asthma. This disease significantly affects airflow to the lungs, leading to symptoms such as abnormal breathing, excessive mucus production, and persistent coughing. According to the World Health Organization (WHO), approximately 3.17 million deaths worldwide were attributed to COPD in 2015. Although COPD is preventable and treatable, effective therapies to reverse lung damage remain elusive.

Research Findings on Cancer Drugs as COPD Treatment

Recent research published in the eLife Journal has explored the potential of certain cancer drugs as innovative treatments for COPD. The inflammatory processes associated with COPD contribute to irreversible lung damage, primarily driven by white blood cells called neutrophils. These cells are known to exacerbate inflammation in the lungs.

To investigate the impact of cancer drugs on inflammation and COPD, researchers screened a variety of cancer medications and identified specific compounds that not only induced neutrophil death but also promoted healing in lung tissue.

Identified Drug Candidates

The study highlighted three candidate cancer drugs: gefitinib, erbstatin, and tyrphostin AG825. These drugs were found to enhance apoptosis, or programmed cell death, of the harmful neutrophils. Notably, experiments conducted on mice treated with tyrphostin AG825 demonstrated significant reductions in lung inflammation and increased levels of neutrophil apoptosis.

Implications for Future Research

The findings from this study underscore the therapeutic promise of these cancer drugs in addressing neutrophil-mediated inflammatory diseases, including COPD. However, further research is essential to validate these results and to advance towards human clinical trials.

References

Chronic obstructive pulmonary disease (COPD). (n.d.). Retrieved from https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
Rahman, A., Henry, K. M., Herman, K. D., Thompson, A. A., Isles, H. M., Tulotta, C., … Prince, L. R. (2019). Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation. ELife, 8. doi: 10.7554/elife.50990
Sheffielduni. (n.d.). Cancer drugs could potentially treat COPD, Sheffield research finds. Retrieved from https://www.eurekalert.org/pub_releases/2020-01/uos-cdc010620.php
Image by luvqs from Pixabay